Carisoprodol

Carisoprodol is a carbamate ester that is the mono-N-isopropyl derivative of meprobamate (that is a significant metabolite). Carisoprodol interrupts neuronal communication within the reticular formation and spinal cord, resulting in sedation and alteration in pain perception. It is used as a muscle relaxant in the symptomatic treatment of musculoskeletal conditions associated with painful muscle spasm. Among its listed roles, it functions as a muscle relaxant. It is grouped under the following drug class(es): Schedule IV controlled substances. Its therapeutic use is listed as muscle relaxants. The directory classifies it as a commercial API with a synthetic source/manufacturing origin. Other names for this substance include Brianil, Calenfa and Carisol. It is listed as a controlled drug substance (Schedule IV). Its PubChem CID is 2576.